Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment.

MLA

Wisialowski, Todd A., et al. “Improving the in Vivo QTc Assay: Nonclinical Concentration-QTc Modeling for Risk Assessment.” Journal of Pharmacological and Toxicological Methods, vol. 128, July 2024, p. 107515. EBSCOhost, https://doi.org/10.1016/j.vascn.2024.107515.

APA

Wisialowski, T. A., Ether, N., Foley, C. M., Kleiman, R., Koshman, Y., Leishman, D., Martel, E., Nichols, J. V., Popp, J., Rajamani, S., Riley, S., Rossman, E. I., & Vargas, H. M. (2024). Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment. Journal of Pharmacological and Toxicological Methods, 128, 107515. https://doi.org/10.1016/j.vascn.2024.107515

Chicago

Wisialowski, Todd A, Nick Ether, C Michael Foley, Robert Kleiman, Yevgeniya Koshman, Derek Leishman, Eric Martel, et al. 2024. “Improving the in Vivo QTc Assay: Nonclinical Concentration-QTc Modeling for Risk Assessment.” Journal of Pharmacological and Toxicological Methods 128 (July): 107515. doi:10.1016/j.vascn.2024.107515.